2018
-
Sep 13, 2018 • PRESS RELEASESanofi to refocus two global business unitsMay 21, 2018 • PRESS RELEASESanofi Appoints Amal Makhloufi BenchoukMay 14, 2018 • PRESS RELEASESanofi and Ablynx Announce the Successful Results of the Initial Tender OfferApr 27, 2018 • PRESS RELEASEQ1 2018 ResultsApr 19, 2018 • PRESS RELEASESanofi Pasteur communication on SAGE recommendation about dengue vaccineApr 17, 2018 • PRESS RELEASEAdvent International enters into exclusive negotiations to acquire Sentiva, Sanofi's european generics businessApr 1, 2018 • PRESS RELEASESanofi to invest €350 million in Canadian vaccine facilityMar 29, 2018 • PRESS RELEASETender Offers by Sanofi to acquire AblynxMar 18, 2018 • PRESS RELEASEEvotec and Sanofi in exclusive talks to create an Evotec-led Infectious Disease open innovation R&D platformMar 10, 2018 • PRESS RELEASEPraluent ODYSSEY OUTCOMESMar 10, 2018 • PRESS RELEASESanofi completes acquisition of BioverativFeb 7, 2018 • PRESS RELEASEQ4 2017 ResultsJan 29, 2018 • PRESS RELEASESanofi to acquire Ablynx for €3.9 billionJan 22, 2018 • PRESS RELEASESanofi to acquire BioverativJan 8, 2018 • PRESS RELEASESanofi Investor Agreement Release
2017
-
Dec 4, 2017 • PRESS RELEASESanofi’s Toujeo® met main objective in head-to-head study versus insulin degludecDec 4, 2017 • PRESS RELEASESanofi updates information on dengue vaccine in PhilippinesNov 29, 2017 • PRESS RELEASESanofi updates information on dengue vaccineOct 24, 2017 • PRESS RELEASESanofi Files Suit in the U.S. to Defend Its Patent Rights on Lantus® and Lantus® SoloStar®Oct 12, 2017 • PRESS RELEASESanofi invests €170 million in new vaccine production facility in France
SAPH.SA.19.12.0496 Version 3.6
22 January 2020You are about to leave Sanofi.ph
By clicking on Proceed, you will be redirected to Global Website.
Do you wish to Proceed ?